U.S. Patent 12,349,724 was issued to Cabbacis (CABI) for vaporizer pods with 95% reduced-nicotine tobacco and hemp and ...

The focus is on industrial property rights and the development of patent registration procedures that provide flexible and ...

Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical ...

The United Arab Emirates and the United States of America signed a Joint Statement of Intent aimed at launching a bilateral ...

GM has filed a patent application for a vehicle system capable of predicting road deterioration, providing an alert for ...

After being a regular presence in their living rooms, All Elite Wrestling seems to be heading to fans' kitchens.

“Expanding our intellectual property portfolio is a key part of our strategy,” said John Erb, Chief Executive Officer of Nuwellis. “Each new patent reinforces our commitment to building long-term ...

Cyber A.I. Group Files Patent for Market Disruptive CyberAI Sentinel 2.0 AI-driven Cybersecurity Technology Intelligent and ...

The 119th Congress is in full swing, and one priority should be reforming the U.S. Patent and Trademark Office's (USPTO) quasi-judicial patent review board.

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumor ...

Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042: Minneapolis Thursday, July 17, 2025, 16:00 Hrs [IST] Minneapolis-headquartere ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance ...